In contrast, IKBKG, also known as NF-κB essential modulator (NEMO), is required for the activation of the NF-κB complex by proinflammatory stimuli, and it has recently been recognized as suppressor of hepatic steatosis, possibly through the negative interaction with PPARs [39]–[42]. Here, NFKB1 is linked to fatty liver disease.